Molecular Mechanisms for Construction of Protective Mucus Hydrogels
This project aims to elucidate the molecular mechanisms of mucin glycoprotein assembly into hydrogels, enhancing our understanding for potential therapeutic applications in various diseases.
Projectdetails
Introduction
Our bodies produce copious mucus daily to shield vulnerable epithelial cell surfaces in the lungs, intestines, and other organs. Mucus is crucial for defense against pathogens and other environmental hazards, but the mechanisms by which mucus hydrogels assemble and execute their functions are poorly understood. The main obstacle has been that the enormous, heavily glycosylated, and flexible mucin proteins constituting mucus are not readily amenable to structural and molecular approaches. However, I contend that mucin glycoproteins have exquisitely specific abilities and interactions that are ultimately understandable on the molecular level.
Research Plan
By carrying out the research plan described herein, we will crack the code that transforms the primary building blocks of mucins into diverse three-dimensional, dynamic, and active hydrogels. Specifically, we will:
- Test the hypothesis that glycosylated mucin regions are tunable entropic spacers that influence the positioning and adhesion of neighboring folded domains.
- Control mucin assembly and hydrogel formation.
- Solve the first high-resolution structures of respiratory mucins.
- Develop an experimental and theoretical framework for analyzing the spans and dynamics of O-glycosylated mucin domains.
Recent Discoveries
Perhaps most exciting is our recent discovery that the redox set-point of the Golgi apparatus influences sialic acid decoration of O-glycans during mucus biosynthesis. This finding has potential implications for mucus biophysics and viral penetration.
Future Directions
We will explore the benefits of this regulatory pathway for:
- Mucin self-assembly
- Hydrogel properties
- Mucus barrier function
Together, this work will pave the way toward rationally manipulating mucus hydrogels, offering new avenues for the treatment of inflammatory, fibrotic, and infectious diseases.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 2.162.383 |
Totale projectbegroting | € 2.162.383 |
Tijdlijn
Startdatum | 1-5-2023 |
Einddatum | 30-4-2028 |
Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- WEIZMANN INSTITUTE OF SCIENCEpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Dissecting the Functional Role of Mucosal IgA Clonal and Glycoprofiles for Effective Humoral Mucosal ProtectionThis project aims to characterize mucosal IgA proteoforms to enhance vaccine and monoclonal antibody development for improved respiratory immunity against viral threats. | ERC Starting... | € 1.486.245 | 2025 | Details |
Glycan Mimetics for Cell Glycocalyx Reconstitution: a polymer chemist’s approach to fight infectionGLYMCE aims to uncover how carbohydrates influence pathogen interactions to create innovative glycopolymer materials for infection prevention and treatment. | ERC Consolid... | € 1.994.024 | 2024 | Details |
Isotopically labelling of cell surface glycans to illuminate infectious processes at atomic resolutionGlyco13Cell aims to chemically remodel cell surface glycans using NMR probes to enhance understanding of glycan-lectin interactions for developing novel tools in infectious disease treatment. | ERC Starting... | € 1.500.000 | 2023 | Details |
Mucociliary adaptations and gut microbiome establishment in XenopusThe MAGIX project aims to uncover mechanisms controlling cell type compositions in mucociliary epithelia to predict organ functions and address diseases linked to these adaptations. | ERC Consolid... | € 1.995.921 | 2025 | Details |
Supramolecular & Covalent Bonds for Engineering Spatiotemporal Complexity in Hydrogel BiomaterialsThe project aims to develop tough, spatiotemporally responsive hydrogels by combining dynamic supramolecular assemblies with covalent bonds for innovative biomaterial applications. | ERC Consolid... | € 2.000.000 | 2024 | Details |
Dissecting the Functional Role of Mucosal IgA Clonal and Glycoprofiles for Effective Humoral Mucosal Protection
This project aims to characterize mucosal IgA proteoforms to enhance vaccine and monoclonal antibody development for improved respiratory immunity against viral threats.
Glycan Mimetics for Cell Glycocalyx Reconstitution: a polymer chemist’s approach to fight infection
GLYMCE aims to uncover how carbohydrates influence pathogen interactions to create innovative glycopolymer materials for infection prevention and treatment.
Isotopically labelling of cell surface glycans to illuminate infectious processes at atomic resolution
Glyco13Cell aims to chemically remodel cell surface glycans using NMR probes to enhance understanding of glycan-lectin interactions for developing novel tools in infectious disease treatment.
Mucociliary adaptations and gut microbiome establishment in Xenopus
The MAGIX project aims to uncover mechanisms controlling cell type compositions in mucociliary epithelia to predict organ functions and address diseases linked to these adaptations.
Supramolecular & Covalent Bonds for Engineering Spatiotemporal Complexity in Hydrogel Biomaterials
The project aims to develop tough, spatiotemporally responsive hydrogels by combining dynamic supramolecular assemblies with covalent bonds for innovative biomaterial applications.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Understanding the potential of modulating Host-Microbiome-Glycan interactions (“the triangle of sweetness”) to tackle non-communicable diseasesThe project aims to identify novel glycosyltransferases and HMOs, analyze their gut interactions, and validate an HMO for inflammation relief, enhancing glycobiology research and therapeutic applications. | EIC Pathfinder | € 3.920.718 | 2024 | Details |
Inhibitor-Mediated Programming of GlycoformsThe project aims to revolutionize glycan manipulation using Inhibitor-Mediated Programming of Glycoforms (IMProGlyco) to create precision-engineered therapeutic proteins and enhance cellular functions. | EIC Pathfinder | € 2.998.878 | 2025 | Details |
Understanding the potential of modulating Host-Microbiome-Glycan interactions (“the triangle of sweetness”) to tackle non-communicable diseases
The project aims to identify novel glycosyltransferases and HMOs, analyze their gut interactions, and validate an HMO for inflammation relief, enhancing glycobiology research and therapeutic applications.
Inhibitor-Mediated Programming of Glycoforms
The project aims to revolutionize glycan manipulation using Inhibitor-Mediated Programming of Glycoforms (IMProGlyco) to create precision-engineered therapeutic proteins and enhance cellular functions.